Tyra Biosciences Stock (NASDAQ: TYRA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 130.842K |
Day Range | - - - |
52 Wk Range | 10.380 - 20.670 |
Market Cap | $947.005M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 11.24% |
Days to Cover | 25.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tyra Biosciences (NASDAQ: TYRA) through any online brokerage.
Other companies in Tyra Biosciences’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Tyra Biosciences (NASDAQ: TYRA) was reported by Wedbush on Thursday, March 21, 2024. The analyst firm set a price target for 28.00 expecting TYRA to rise to within 12 months (a possible 55.30% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Tyra Biosciences (NASDAQ: TYRA) is $18.03 last updated May 8, 2024 at 4:15 PM EDT.
There are no upcoming dividends for Tyra Biosciences.
Tyra Biosciences’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Tyra Biosciences.
Tyra Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.